The MSDS format adheres to the standards and regulatory requirements
of the United States and may not meet regulatory requirements
in other countries.
DuPont Page 1
Material Safety Data Sheet
----------------------------------------------------------------------
"VERTREL" XMS Plus
6155FR Revised 11-FEB-2005
----------------------------------------------------------------------
----------------------------------------------------------------------
CHEMICAL PRODUCT/COMPANY IDENTIFICATION
----------------------------------------------------------------------
Material Identification
"VERTREL" is a registered trademark of DuPont.
Formula : CF3CHFCHFCF2CF3,CC1H=C1H(TRANS), CH3OH,
C5H10 (CYCLO)
Company Identification
MANUFACTURER/DISTRIBUTOR
DuPont Fluoroproducts
1007 Market Street
Wilmington, DE 19898
PHONE NUMBERS
Product Information : 1-800-441-7515 (outside the U.S.
302-774-1000)
Transport Emergency : CHEMTREC 1-800-424-9300(outside U.S.
703-527-3887)
Medical Emergency : 1-800-441-3637 (outside the U.S.
302-774-1000)
----------------------------------------------------------------------
COMPOSITION/INFORMATION ON INGREDIENTS
----------------------------------------------------------------------
Components
Material CAS Number %
138495-42-8
1,1,1,2,2,3,4,5,5,5-DECAFLUOROPENTANE (HFC-43- 48-62
10mee)
TRANS, 1,2-DICHLOROETHYLENE (t-DCE) 156-60-5 30-50
CYCLOPENTANE 287-92-3 2-6
*METHANOL 67-56-1 4-8
NITROMETHANE 75-52-5 0.05-0.5
* Disclosure as a toxic chemical is required under Section 313 of
Title III of the Superfund Amendments and Reauthorization Act of 1986
and 40 CFR part 372.
6155FR DuPont Page 2
Material Safety Data Sheet
----------------------------------------------------------------------
HAZARDS IDENTIFICATION
----------------------------------------------------------------------
Potential Health Effects
Gross overexposure by inhalation to HFC-43-10mee may cause
suffocation if air is displaced by vapors and central
nervous system stimulation with increased activity or
sleeplessness, tremors or convulsions. These effects may be
followed by central nervous system depression with
dizziness, confusion, incoordination, drowsiness or
unconsciousness. Based on data from other fluorocarbons,
gross overexposure may be associated with irregular
heartbeat or heart rhythm, which may produce heart
palpitation, dizziness, weakness, unconsciousness and death.
It is unlikely that concentrations sufficient to produce
irregular heartbeat or heart rhythm would be achieved from
HFC-43-10MEE without first producing other signs of
toxicity. Immediate effects of overexposure to HFC-43-10mee
by skin contact may include slight irritation with itching,
redness or swelling. Repeated and/or prolonged exposure may
cause defatting of the skin with itching, redness or rash.
Based on animal data, significant skin permeation, and
systemic toxicity after skin contact, appears unlikely.
Immediate effects of overexposure to HFC-43-10mee by eye
contact may include eye irritation with tearing, pain or
blurred vision. The major ingestion hazard of HFC-43-10mee
is aspiration (liquid entering the lungs during ingestion or
vomiting) which may result in "chemical pneumonia." Symptoms
include coughing, gasping, choking, shortness of breath,
bluish discoloration of the skin, rapid breathing and heart
rate, and fever. Pulmonary edema or bleeding, drowsiness,
confusion, coma and seizures may occur in more serious
cases. Symptoms may develop immediately or as late as 24
hours after exposure, depending on how much chemical entered
the lungs. Increased susceptibility to the effects of
HFC-43-10mee may be observed in persons with pre-existing
disease of the central nervous system or the cardiovascular
system.
Inhalation of t-DCE may cause central nervous system
depression with dizziness, confusion, incoordination,
drowsiness or unconsciousness; or tremors, nausea, vomiting,
weakness, and abdominal cramps. Other effects may include
irregular heart beat with a strange sensation in the chest,
"heart thumping",apprehension, lightheadedness, feeling of
fainting, dizziness, or weakness. Skin contact with t-DCE
may cause severe irritation with burning, redness, swelling,
pain or rash. Eye contact with t-DCE may cause severe eye
irritation with tearing, pain or blurred vision. Ingestion
of t-DCE may cause pulmonary edema (body fluid in the lungs)
with cough, wheezing, abnormal lung sounds, possibly
progressing to severe shortness of breath and bluish
discoloration of the skin: symptoms may be delayed.
Ingestion may also cause pathological changes in the liver,
central nervous system depression with dizziness, confusion,
6155FR DuPont Page 3
Material Safety Data Sheet
(HAZARDS IDENTIFICATION - Continued)
incoordination, drowsiness or unconsciousness, and
structural (pathological) changes in heart muscle tissue.
Inhalation of Cyclopentane may cause central nervous system
depression with dizziness, confusion, incoordination,
drowsiness or unconsciousness; and non-specific effects such
as headache, nausea and weakness. Repeated and/or prolonged
exposure may cause peripheral nervous system effects with
tingling, pain, or loss of sensation in extremities which
may by accompanied by weakness or loss of muscle control.
Higher exposures may cause "heart thumping", apprehension,
lightheadedness, feeling of fainting, dizziness, weakness,
sometimes progressing to loss of consciousness and death.
Skin contact with Cyclopentane may cause defatting of the
skin with itching, redness or rash. Eye contact with liquid
or high vapor concentrations of Cyclopentane may cause eye
irritation with tearing, pain or blurred vision. Ingestion
of Cyclopentane may cause gastrointestinal irritation with
pain or diarrhea. The major ingestion hazard is aspiration
(liquid entering the lungs during ingestion or vomiting)
which may result in "chemical pneumonia". Symptoms include
coughing, gasping, choking, shortness of breath, bluish
discoloration of the skin, rapid breathing and heart rate,
and fever. Pulmonary edema or bleeding, drowsiness,
confusion, coma and seizures may occur in more serious
cases. Symptoms may develop immediately or as late as 24
hours after exposure, depending on how much chemical entered
the lungs. Increased susceptibility to the effects of
Cyclopentane may be observed in persons with pre-existing
disease of the central nervous or cardiovascular systems.
The fatal dose of Methyl Alcohol by ingestion is from 60 to
250 ml. Inhalation of Methyl Alcohol may cause irritation of
the nose and throat with sneezing, sore throat or runny
nose. Skin contact with Methyl Alcohol may cause irritation
with itching, burning, redness, swelling or rash. Skin
permeation may occur in amounts capable of producing the
effects of systemic toxicity. Eye contact with Methyl
Alcohol may cause eye irritation with tearing, pain or
blurred vision. Ingestion of Methyl Alcohol may cause
irritation of the digestive tract with stomach pain,
heartburn, nausea, vomiting or diarrhea; however there may
be no symptoms at all. Inhalation, ingestion or skin contact
with Methyl Alcohol may cause temporary mild depression of
the central nervous system with dizziness, confusion,
incoordination or drowsiness followed by an asymptomatic
period usually ranging from 12 to 24 hours. Metabolic
acidosis develops followed by ocular toxicity (visual
disturbance including blindness). Other effects include
non-specific effects such as headache, nausea and weakness.
Gross overexposure may cause pathological changes in the
liver and kidneys; nerve damage with numbness, weakness or
muscle rigidity; tremors; convulsions; and fatality.
Increased susceptibility to the effects of Methyl Alcohol
6155FR DuPont Page 4
Material Safety Data Sheet
(HAZARDS IDENTIFICATION - Continued)
may be observed in persons with pre-existing disease of the
nervous system, visual system, liver, kidneys, and
cardiovascular system.
Short-term overexposure by inhalation to Nitromethane may
cause irritation of the nose and throat with sneezing, sore
throat or runny nose. Based on animal data repeated and/or
prolonged exposure may cause irritation of nose, throat, and
lungs with cough, difficulty breathing or shortness of
breath, pathological changes in the liver, central nervous
system depression with dizziness, confusion, incoordination,
drowsiness or unconsciousness, peripheral nervous system
effects with tingling, pain, or loss of sensation in
extremities which may be accompanied by weakness or loss of
muscle control, altered blood cell counts, impaired
functioning of the blood-forming system with alterations in
blood cell counts and/or anemia, effects on the nervous
tissue, and clinical pathological changes of the thyroid.
Skin contact with Nitromethane may cause skin irritation
with itching, burning, redness, swelling or rash. Eye
contact with Nitromethane may cause eye irritation with
tearing, pain or blurred vision. Based on animal data,
ingestion of Nitromethane may cause abnormal liver function
with altered enzyme levels in blood, or abnormal kidney
function with altered results on blood tests.
# Carcinogenicity Information
The following components are listed by IARC, NTP, OSHA or ACGIH as
carcinogens.
Material IARC NTP OSHA ACGIH
NITROMETHANE 2B X A3
----------------------------------------------------------------------
FIRST AID MEASURES
----------------------------------------------------------------------
First Aid
INHALATION
If inhaled, immediately remove to fresh air. Keep person calm.
If not breathing, give artificial respiration. If breathing is
difficult, give oxygen. Call a physician.
SKIN CONTACT
Flush skin with water after contact. Wash contaminated clothing
before reuse.
EYE CONTACT
In case of contact, immediately flush eyes with plenty of water
for at least 15 minutes. Call a physician.
6155FR DuPont Page 5
Material Safety Data Sheet
(FIRST AID MEASURES - Continued)
INGESTION
If swallowed, immediately give 2 glasses of water and induce
vomiting. Never give anything by mouth to an unconscious person.
Call a physician.
Notes to Physicians
Ethanol (ETOH) is antidotal and should be administered early in
the treatment. Ethanol is a potent inhibitor of Methanol
metabolism because it is preferentially acted on by liver alcohol
dehydrogenase, thus delaying or preventing toxic metabolites from
Methanol.
Treatment is started after residual ingested substance is removed
from the stomach. Ethanol is administered orally or IV with a
goal of maintaining a blood alcohol level of approximately 22
mmol/L or 1.0 mg/L.
To prepare antidote, make a solution using 100 mL of 100 proof
ethyl alcohol and 1900 mL of water. Give 1.5 mL/kg or 100 mL for
an average adult. This may be mixed with orange juice for oral
use if necessary. More Ethanol is to be given at 2 hour intervals
to achieve and maintain the desired blood alcohol levels.
Treatment may be necessary for several days.
The patient should be monitored for metabolic acidosis. Use of
appropriate buffering solutions, such as bicarbonate, may be
indicated.
Hemodialysis may be required.
THIS MATERIAL MAY MAKE THE HEART MORE SUSCEPTIBLE TO ARRHYTHMIAS.
Catecholamines such as adrenaline, and other compounds having
similar effects, should be reserved for emergencies and then used
only with special caution.
----------------------------------------------------------------------
FIRE FIGHTING MEASURES
----------------------------------------------------------------------
Flammable Properties
Flammable limits in Air, % by Volume
LEL : 6.0 %
UEL : 15.0 %
6155FR DuPont Page 6
Material Safety Data Sheet
(FIRE FIGHTING MEASURES - Continued)
Flash Point : None.
Method : Pensky-Martens Closed Cup (ASTM D 93)
Flash Point : 20 deg C (no fire point)
Method : Tag Open Cup (ASTM D 1310)
AUTOIGNITION TEMPERATURE and FLAMMABLE LIMITS IN AIR:
Has not yet been determined for "Vertrel" XMS Plus.
Fire and Explosion Hazards:
Use water spray or fog to cool containers. Drums may
rupture under fire conditions. Decomposition may occur.
Extinguishing Media
Water Spray, Water Fog, Dry Chemical, CO2.
Fire Fighting Instructions
Self-contained breathing apparatus (SCBA) is required if
drums rupture and contents are spilled under fire
conditions.
----------------------------------------------------------------------
ACCIDENTAL RELEASE MEASURES
----------------------------------------------------------------------
Safeguards (Personnel)
NOTE: Review FIRE FIGHTING MEASURES and HANDLING (PERSONNEL)
sections before proceeding with clean-up. Use appropriate
PERSONAL PROTECTIVE EQUIPMENT during clean-up.
Initial Containment
Dike spill. Prevent material from entering sewers, waterways, or
low areas.
Spill Clean Up
Soak up with sawdust, sand, oil dry or other absorbent material.
Immediately evacuate the area and provide maximum
ventilation, especially in low places where heavy vapors
might collect. Unprotected personnel should move upwind of
spill. Only personnel equipped with proper respiratory and
skin/eye protection should be permitted in area. Soak up
with sawdust, sand, oil dry or other absorbent material.
After all visible traces, including ignitable vapors, have
been removed, thoroughly wet vacuum the area. Do not flush
to sewer. If area of spill is porous, remove as much
contaminated earth and gravel, etc. as necessary and place
in closed containers for disposal.
6155FR DuPont Page 7
Material Safety Data Sheet
(ACCIDENTAL RELEASE MEASURES - Continued)
In spill or leak situations, the composition of vapors above
the liquid may fall within the LEL/UEL and, therefore,
become flammable. Provide ventilation and assure no
ignition sources are present.
----------------------------------------------------------------------
HANDLING AND STORAGE
----------------------------------------------------------------------
Handling (Personnel)
Avoid breathing vapors or mist. Avoid contact with eyes, skin, or
clothing. Wash thoroughly after handling.
The use of gloves is recommended when working with the
material containers. Material should not be dispensed from
its container by pouring, except for small sample containers
where fume hoods or where other ventilation is used to
manage the exposure limits. The use of a drum pump is
recommended for dispensing from shipping containers.
Storage
Store in a clean, dry area. Do not allow stored product to
exceed 52 C (125 F) to prevent leakage or potential rupture
of container from pressure and expansion. Protect from
freezing temperatures. If solvent is stored below -10 C
(14 F), mix prior to use.
----------------------------------------------------------------------
EXPOSURE CONTROLS/PERSONAL PROTECTION
----------------------------------------------------------------------
Engineering Controls
Use only with adequate ventilation. Keep container tightly closed.
Vapors are heavier than air posing a hazard of asphyxia if
they are trapped in enclosed or low places.
Personal Protective Equipment
EYE/FACE PROTECTION
Wear safety glasses or coverall chemical splash goggles.
RESPIRATORS
Where there is potential for airborne exposures in excess of
applicable limits, wear NIOSH approved respiratory
protection.
PROTECTIVE CLOTHING
Where there is potential for skin contact have available and
wear as appropriate impervious gloves, apron, pants, and
6155FR DuPont Page 8
Material Safety Data Sheet
(EXPOSURE CONTROLS/PERSONAL PROTECTION - Continued)
jacket.
Protective gloves and chemical splash goggles should be used
when handling liquid.
Exposure Guidelines
Applicable Exposure Limits
1,1,1,2,2,3,4,5,5,5-DECAFLUOROPENTANE (HFC-43-10mee)
PEL (OSHA) : None Established
TLV (ACGIH) : None Established
AEL * (DuPont) : 200 ppm, 8 & 12 Hr. TWA
400 ppm, Ceiling
TRANS, 1,2-DICHLOROETHYLENE (t-DCE)
PEL (OSHA) : 200 ppm, 790 mg/m3, 8 Hr. TWA
TLV (ACGIH) : 200 ppm, 8 Hr. TWA
AEL * (DuPont) : 200 ppm, 8 & 12 Hr. TWA
CYCLOPENTANE
PEL (OSHA) : None Established
TLV (ACGIH) : 600 ppm, 1,720 mg/m3, 8 Hr. TWA
AEL * (DuPont) : 600 ppm, 8 & 12 Hr. TWA
METHANOL
PEL (OSHA) : 200 ppm, 260 mg/m3, 8 Hr. TWA
TLV (ACGIH) : 200 ppm, 8 Hr. TWA, Skin
STEL 250 ppm
AEL * (DuPont) : 200 ppm, 8 & 12 Hr. TWA, Skin
NITROMETHANE
PEL (OSHA) : 100 ppm, 250 mg/m3, 8 Hr. TWA
TLV (ACGIH) : 20 ppm, 8 Hr. TWA, A3
AEL * (DuPont) : 10 ppm, 8 & 12 Hr. TWA
* AEL is DuPont鈥檚 Acceptable Exposure Limit. Where governmentally
imposed occupational exposure limits which are lower than the AEL
are in effect, such limits shall take precedence.
----------------------------------------------------------------------
PHYSICAL AND CHEMICAL PROPERTIES
----------------------------------------------------------------------
Physical Data
Boiling Point : 38.0 C (100.4 F)
Vapor Pressure : 470 mm Hg @ 25 C (77 F)
Vapor Density : 4.3 (Air=1.0)
Form : Liquid
Color : Colorless
Density : 1.34 g/cm3 @ 25 C (77 F)
11.2 lb/gal
6155FR DuPont Page 9
Material Safety Data Sheet
----------------------------------------------------------------------
STABILITY AND REACTIVITY
----------------------------------------------------------------------
Chemical Stability
Stable at normal temperatures and storage conditions.
Incompatibility with Other Materials
Incompatible with alkali or alkaline earth metals - powdered
Al, Zn, Be, Na, Mg, etc.
Incompatible with strong bases such as NaOH, KOH, etc.
Decomposition
Decomposes with heat. High temperatures (open flames,
glowing metal surfaces, etc.) can decompose HFC-43-10mee
forming hydrofluoric acids and possibly carbonyl halides.
HFC-43-10mee is incompatible with strong bases and can react
to form salts of hydrofluoric acid and unsaturated compounds
of unknown toxicity.
1,2-Trans DCE is unstable at high temperatures and will form
hydrochloric acid and unsaturates as well as break down or
react in the presence of caustic to form salts of
hydrochloric acid.
Polymerization
Polymerization will not occur.
----------------------------------------------------------------------
TOXICOLOGICAL INFORMATION
----------------------------------------------------------------------
Animal Data
HFC-43-10mee
Oral LD50: > 5,000 mg/kg in rats
Dermal ALD: > 5,000 mg/kg in rabbits
Inhalation, 4 hour LC50: 11,100 ppm in rats
t-DCE
Oral LD50: 1275 mg/kg in rats
Dermal LD50: > 5000 mg/kg in rabbits
Inhalation LC50, 4 hr: 24,100 ppm in rats
Cyclopentane
Inhalation 2 hour ALC: 38,390 ppm in mice
Methyl Alcohol
6155FR DuPont Page 10
Material Safety Data Sheet
(TOXICOLOGICAL INFORMATION - Continued)
Oral LD50: 9,100 mg/kg in rats
Dermal LD50 15,840 mg/kg in rabbits
Inhalation 1 hour LC50: > 145,000 ppm in rats
Nitromethane
Inhalation 4 hour ALC: 6000 ppm in rats
Oral LD50: 1210 mg/kg in rats
Dermal LD50: > 2000 mg/kg in rabbits
Animal testing indicates that HFC-43-10mee is a slight skin
irritant and a mild eye irritant, but is not a skin
sensitizer. HFC-43-10mee did not cause cardiac sensitization
in dogs exposed to 1000 or 5000 ppm. The cardiac
sensitization potential was not evaluated at or above 10,000
ppm due to clinical signs consistent with central nervous
system toxicity. Single exposure to 5,000 ppm HFC-43-10mee
by inhalation caused tremors. A different single exposure
study by inhalation in rats caused incoordination,
hyperactivity and prostration; pathological examination of
rats from this study revealed kidney and lung changes, and
external hair loss. Repeated exposures to 1,900 - 3,500 ppm
caused tremors or convulsions, behavioral effects, and
altered clinical chemistry. In developmental toxicity
studies with laboratory animals, HFC-43-10mee was not
uniquely toxic to the developing fetus. No animal data are
available to define the carcinogenic or reproductive hazards
of HFC-43-10mee. Tests have shown that HFC-43-10mee does
not cause genetic damage in bacterial or mammalian cell
cultures. It has not produced genetic damage in tests on
animals.
t-DCE is a severe eye irritant, and a moderate to severe
skin irritant. Single and repeated exposure to t-DCE by
ingestion caused increased kidney weight, histopathological
changes of the lungs, liver effects, decreased motor
activity, pulmonary edema, cardiovascular system changes,
and mortality. Single and repeated exposure to t-DCE by
inhalation caused pathological changes of the liver and
lungs, inactivity or anaesthesia, altered white blood cell
count, cardiovascular system changes and weak cardiac
sensitization, a potentially fatal disturbance of the heart
rhythm caused by a heightened sensitivity to the action of
epinephrine. Long-term exposure caused altered liver and
lung function. A more recent inhalation study (Dec. 1998)
conducted with well-characterized t-DCE containing > 99.4%
t-DCE, produced no adverse, compound-related effects. The
NOEL was 4000 ppm. Exposure of pregnant rats shows maternal
toxicity at 2000, 6000 and 12,000 ppm. Developmental
toxicity was seen only at 12,000 ppm. Tests have shown that
t-DCE does not cause genetic damage in bacterial or
mammalian cell cultures. No animal data are available to
define the carcinogenic or reproductive hazards of t-DCE.
6155FR DuPont Page 11
Material Safety Data Sheet
(TOXICOLOGICAL INFORMATION - Continued)
Animal testing indicates that Cyclopentane is a slight skin
irritant. Single exposure by inhalation to Cyclopentane
caused inactivity or anaesthesia, altered righting reflexes,
and cardiac sensitization, a potentially fatal disturbance
of heart rhythm associated with a heightened sensitivity to
the action of epinephrine. No animal data are available to
define the carcinogenicity, developmental, reproductive or
mutagenic hazards of Cyclopentane.
Animal testing indicates Methyl Alcohol is an eye and skin
irritant. Eye contact with Methyl Alcohol caused clouding of
the eye (corneal opacity). Repeated skin contact with higher
concentrations of Methyl Alcohol caused some mortality.
Single exposure by ingestion caused narcosis, liver effects,
and hypothermia. Repeated exposure caused pathological
changes of the eyes and acidosis. Repeated exposure by
inhalation caused irritation of the eyes, and blindness. No
animal data are available to define the carcinogenicity of
Methyl Alcohol. Exposure of pregnant rats shows the
following developmental effects: reduced birth weight, bone
abnormalities, and behavioral abnormalities. Exposure of
pregnant mice shows the following developmental effects:
reduced birth weight, resorption, and bone abnormalities.
No adequate animal data are available to define the
reproductive effects of Methyl Alcohol. Tests have shown
that Methyl Alcohol does not cause genetic damage in
bacterial or mammalian cell cultures, or in animals. Methyl
Alcohol has not been tested for its ability to cause
permanent genetic damage in reproductive cells of mammals
(not tested for heritable genetic damage).
Nitromethane is a skin irritant, and a slight eye irritant,
but is not a skin sensitizer in animals. Single inhalation
exposure to Nitromethane caused upper respiratory tract
irritation, liver and kidney effects, central nervous system
depression, incoordination, eye irritation, and some
mortality. Repeated inhalation exposures caused loss of
mobility in the hind limbs, alterations to the blood-forming
system, altered hematology and clinical chemistry,
respiratory testicular effects, reduced sperm counts,
altered estrous cycle, degeneration of the sciatic nerve,
and spinal cord. Long-term exposure caused reduced weight
gain, altered hematology, increased thyroid weight,
decreased thyroxine levels and pathological changes of the
lungs. Single ingestion exposure to high doses caused
histopathological changes of the liver and kidney injury.
Repeated exposures caused reduced weight gain, and liver
injury. Repeated dermal exposure caused no significant
toxicological effects. In one study, Nitromethane produced
evidence of carcinogenic activity in male and female mice
exposed to concentrations of 188, 375, or 750 ppm for 2
years, and in female rats exposed to concentrations of 94,
188, or 375 ppm for 2 years. There was no evidence of
carcinogenic activity in male rats exposed for 2 years to
6155FR DuPont Page 12
Material Safety Data Sheet
(TOXICOLOGICAL INFORMATION - Continued)
concentrations of 94, 188, or 375 ppm. In a different
study, with male and female rats exposure to concentrations
of 100 or 200 ppm for 2 years did not produce evidence of
carcinogenic activity. No adequate animal data are available
to define the developmental or reproductive toxicity of
Nitromethane. Tests have shown that Nitromethane did not
cause genetic damage in bacterial or mammalian cell
cultures.
----------------------------------------------------------------------
ECOLOGICAL INFORMATION
----------------------------------------------------------------------
Ecotoxicological Information
AQUATIC TOXICITY
HFC-43-10mee:
96 hour LC50 - fathead minnows: 27.2 mg/L
96 hour LC50 - rainbow trout: 13.9 mg/L
48 hour LC50 - Daphnia magna: 11.7 mg/L
t-DCE:
96 hour LC50 - bluegill sunfish: 1350 mg/L
48 hour LC50 - Dapnia magna: 220 mg/L
CYCLOPENTANE:
96 hour LC50 - coho salmon: > 100 mg/L
METHANOL:
96 hour LC50 - fathead minnows: 28,100 mg/L
NITROMETHANE:
96 hour LC50 - fathead minnows: 1710 mg/L
48 hour LC50 - Daphnia magna: 100 mg/L
----------------------------------------------------------------------
DISPOSAL CONSIDERATIONS
----------------------------------------------------------------------
Waste Disposal
Treatment, storage, transportation, and disposal must be in
accordance with applicable Federal, State/Provincial, and Local
regulations.
----------------------------------------------------------------------
TRANSPORTATION INFORMATION
----------------------------------------------------------------------
Shipping Information
DOT/IMO/IATA - Not regulated in containers with less than
2300 lbs. If greater than 2300 lbs., use:
Proper Shipping Name: Environmentally Hazardous Substance,
Liquid, N.O.S. (Trans-1,2-Dichloro-
6155FR DuPont Page 13
Material Safety Data Sheet
(TRANSPORTATION INFORMATION - Continued)
ethylene)
Hazard Class : 9
UN Number : 3082
Packing Group : III
Reportable Quantity : 1000 lbs. (Trans-1,2-Dichloroethylene)
: 5000 lbs. (Methanol)
: 2300 lbs. ("Vertrel" XMS Plus)
----------------------------------------------------------------------
REGULATORY INFORMATION
----------------------------------------------------------------------
U.S. Federal Regulations
All Components Are Listed on the TSCA Public Inventory
TITLE III HAZARD CLASSIFICATIONS SECTIONS 311, 312
Acute : Yes
Chronic : No
Fire : No
Reactivity : No
Pressure : No
1,1,1,2,2,3,4,5,5,5-DECAFLUOROPENTANE (CAS# 138495-42-8) is
controlled by TSCA Section 5, Significant New Use Rule
(SNUR; 40 CFR 721.5645) The approved uses are: precision and
general cleaning, carrier fluid, displacement drying,
printed circuit board cleaning, particulate removal and film
cleaning, process medium, heat transfer fluid (dielectric
and non-dielectric), and test fluid. Processors and users
of this substance must also comply with the applicable
general SNUR requirements set forth in 40 CFR 721 subpart A,
including export notification requirements if applicable (40
CFR 721.20), and the applicable record keeping requirements
set forth at 40 CFR 721.125.
LISTS:
SARA Extremely Hazardous Substance -No
CERCLA Hazardous Substance -Yes*
*Methanol and Trans-1,2-dichloroethylene
State Regulations (U.S.)
"WARNING - SUBSTANCES KNOWN TO THE STATE OF CALIFORNIA TO
CAUSE CANCER - Nitromethane (75-52-5)"
6155FR DuPont Page 14
Material Safety Data Sheet
----------------------------------------------------------------------
OTHER INFORMATION
----------------------------------------------------------------------
NFPA, NPCA-HMIS
NPCA-HMIS Rating
Health :2
Flammability :1
Reactivity :1
Personal Protection rating to be supplied by user depending on use
conditions.
----------------------------------------------------------------------
The data in this Material Safety Data Sheet relates only to the
specific material designated herein and does not relate to use in
combination with any other material or in any process.
Responsibility for MSDS : MSDS Coordinator
> : DuPont Fluoroproducts
Address : Wilmington, DE 19898
Telephone : (800) 441-7515
# Indicates updated section.
This information is based upon technical information believed to be
reliable. It is subject to revision as additional knowledge and
experience is gained.
End of MSDS
|